{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:11:57Z","timestamp":1790698317962,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007732"],"award-info":[{"award-number":["T32DK007732"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Eosinophils in kidney disease are poorly understood and are often incidental findings on kidney biopsy. Eosinophilia in blood and renal biopsy tissue is associated with a host of immune and non-immune kidney diseases. The significance of eosinophilia in renal diseases has not been well addressed. We evaluated the presence of peripheral eosinophilia (&gt;\u20094% of blood leukocytes) with biopsy tissue eosinophilia and their association with end-stage-kidney-disease (ESKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A nested case-control (2:1) of patients who underwent kidney biopsies at Johns Hopkins Hospital and Medical University of South Carolina from 2004 to 2018 were included in the study. From the 616 eligible patients, 178 patients were identified through the registry of kidney biopsies as 18\u2009years or older without missing biopsy reports or hematology results. Controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009154) had no ESKD at the time of case (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200924) designation and were assembled using incident density sampling and matched on age and sex. The association of peripheral eosinophilia (&gt;\u20094% of peripheral blood leukocytes) with the risk of progression to ESKD was evaluated using conditional logistic model after adjusting for clinical demographics.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 178 patients, 65 (37%) had peripheral eosinophilia and 113 (63%) had no eosinophilia. Compared to patients without eosinophilia, patients with peripheral eosinophilia were notably male and had a higher serum creatinine at the time of their biopsy. Peripheral eosinophilia was associated with higher risk of ESKD (OR 15.9 [1.9, 134.7]) adjusted for patient demographics including hypertension, proteinuria and eGFR at the time of kidney biopsy. Peripheral eosinophilia had a significant linear association with kidney tissue eosinophils, 22 (standard deviation [SD] 20) per high power field (hpf) in 4\u201310% peripheral eosinophilia, 19 (SD 18) per hpf in \u226510% eosinophilia and 3 (SD 7) per hpf in no eosinophilia (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009\u00a00.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Peripheral eosinophilia is an independent predictor of tissue eosinophilia and subsequent progression to ESKD. Peripheral eosinophilia may be an early biomarker for underlying inflammation and disease, but further studies to investigate this clinical association are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-020-1685-3","type":"journal-article","created":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T14:02:57Z","timestamp":1578924177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Eosinophilia and risk of incident end stage kidney disease"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0728-8436","authenticated-orcid":false,"given":"Anam","family":"Tariq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Okamato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azka","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi Z.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim M.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Ploth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Atta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaithin A.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,13]]},"reference":[{"issue":"6","key":"1685_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00296-004-0469-6","volume":"24","author":"A Kargili","year":"2004","unstructured":"Kargili A, Bavbek N, Kaya A, Kosar A, Karaaslan Y. Eosinophilia in rheumatologic diseases: a prospective study of 1000 cases. Rheumatol Int. 2004;24(6):321\u20134.","journal-title":"Rheumatol Int"},{"issue":"8","key":"1685_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/j.1365-2222.2008.03037.x","volume":"38","author":"P Akuthota","year":"2008","unstructured":"Akuthota P, Wang HB, Spencer LA, Weller PF. Immunoregulatory roles of eosinophils: a new look at a familiar cell. Clin Exp Allergy. 2008;38(8):1254\u201363.","journal-title":"Clin Exp Allergy"},{"issue":"11","key":"1685_CR3","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1002\/ajh.24880","volume":"92","author":"J Gotlib","year":"2017","unstructured":"Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol. 2017;92(11):1243\u201359.","journal-title":"Am J Hematol"},{"issue":"3","key":"1685_CR4","first-page":"176","volume":"47","author":"GS Kirkland","year":"1997","unstructured":"Kirkland GS, Savige J, Wilson D, Heale W, Sinclair RA, Hope RN. Classical polyarteritis nodosa and microscopic polyarteritis with medium vessel involvement--a comparison of the clinical and laboratory features. Clin Nephrol. 1997;47(3):176\u201380.","journal-title":"Clin Nephrol"},{"issue":"3","key":"1685_CR5","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.1016\/S0272-6386(03)00802-3","volume":"42","author":"N Ohashi","year":"2003","unstructured":"Ohashi N, Sugiura T, Isozaki T, Yamamoto T, Hishida A. Anti-glomerular basement membrane antibody-induced glomerulonephritis with periglomerular granulomatous reaction and massive renal eosinophilic infiltration. Am J Kidney Dis. 2003;42(3):E28\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"1685_CR6","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4065\/75.6.586","volume":"75","author":"JP Renston","year":"2000","unstructured":"Renston JP, Goldman ES, Hsu RM, Tomashefski JF Jr. Peripheral blood eosinophilia in association with sarcoidosis. Mayo Clin Proc. 2000;75(6):586\u201390.","journal-title":"Mayo Clin Proc"},{"issue":"9","key":"1685_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/S0025-6196(12)62697-4","volume":"63","author":"RM Ten","year":"1988","unstructured":"Ten RM, Torres VE, Milliner DS, Schwab TR, Holley KE, Gleich GJ. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin Proc. 1988;63(9):921\u201330.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"1685_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","volume":"78","author":"L Guillevin","year":"1999","unstructured":"Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore). 1999;78(1):26\u201337.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1685_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/ndt\/gfi299","volume":"21","author":"J Hegarty","year":"2006","unstructured":"Hegarty J, Chiu DY, Middleton RJ, Haeney MM, Newstead CG, Bruce IN, et al. Systemic lupus erythematosus, eosinophilic vasculitis and acalculous cholecystitis. Nephrol Dial Transplant. 2006;21(3):792\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"4\u20135","key":"1685_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10067-003-0725-2","volume":"22","author":"S Kamali","year":"2003","unstructured":"Kamali S, Kasapoglu E, Akturk F, Gul A, Inanc M, Ocal L, et al. Eosinophilia and hyperimmunoglobulinemia E as the presenting manifestations of Wegener's granulomatosis. Clin Rheumatol. 2003;22(4\u20135):333\u20135.","journal-title":"Clin Rheumatol"},{"issue":"8","key":"1685_CR11","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1093\/ndt\/gfq745","volume":"26","author":"CJ Diskin","year":"2011","unstructured":"Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB. The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service. Nephrol Dial Transplant. 2011;26(8):2549\u201358.","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"1685_CR12","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.2215\/CJN.06150613","volume":"9","author":"R Chu","year":"2014","unstructured":"Chu R, Li C, Wang S, Zou W, Liu G, Yang L. Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol. 2014;9(7):1175\u201382.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"1685_CR13","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1685_CR14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1093\/ndt\/gfv067","volume":"30","author":"DF Dai","year":"2015","unstructured":"Dai DF, Sasaki K, Lin MY, Smith KD, Nicosia RF, Alpers CE, et al. Interstitial eosinophilic aggregates in diabetic nephropathy: allergy or not? Nephrol Dial Transplant. 2015;30(8):1370\u20136.","journal-title":"Nephrol Dial Transplant"},{"issue":"30","key":"1685_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004203","volume":"95","author":"PY Chang","year":"2016","unstructured":"Chang PY, Chien LN, Lin YF, Wu MS, Chiu WT, Chiou HY. Risk factors of gender for renal progression in patients with early chronic kidney disease. Med (Baltimore). 2016;95(30):e4203.","journal-title":"Med (Baltimore)"},{"issue":"4","key":"1685_CR16","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","volume":"63","author":"K Iseki","year":"2003","unstructured":"Iseki K, Ikemiya Y, Iseki C, Takishita S. Proteinuria and the risk of developing end-stage renal disease. Kidney Int. 2003;63(4):1468\u201374.","journal-title":"Kidney Int"},{"issue":"5","key":"1685_CR17","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1681\/ASN.2008070730","volume":"20","author":"SI Hallan","year":"2009","unstructured":"Hallan SI, Ritz E, Lydersen S, Romundstad S, Kvenild K, Orth SR. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol. 2009;20(5):1069\u201377.","journal-title":"J Am Soc Nephrol"},{"key":"1685_CR18","volume-title":"Stata Statistical Software: Release 15","author":"StataCorp","year":"2017","unstructured":"StataCorp. Stata Statistical Software: Release 15. College Station: StataCorp LLC; 2017."},{"key":"1685_CR19","unstructured":"Outcomes KDIG. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. 2013;3(3)."},{"issue":"6","key":"1685_CR20","first-page":"320","volume":"14","author":"I Hermida Lazcano","year":"1997","unstructured":"Hermida Lazcano I, Garcia Diez F, Nerin Sanchez C, Martinez Alvarez R, Jimenez SJ. Eosinophilia: initial presentation form of hypernephroma. An Med Interna. 1997;14(6):320\u20131.","journal-title":"An Med Interna"},{"issue":"3","key":"1685_CR21","first-page":"298","volume":"85","author":"M Moroni","year":"2000","unstructured":"Moroni M, Porta C, De Amici M, Quaglini S, Cattabiani MA, Buzio C. Eosinophils and C4 predict clinical failure of combination immunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients. Haematologica. 2000;85(3):298\u2013303.","journal-title":"Haematologica."},{"issue":"24","key":"1685_CR22","first-page":"1218","volume":"27","author":"E Hazouard","year":"1998","unstructured":"Hazouard E, Clement B, Ferrandiere M, Mayelo V, Linassier C, Legras A. Major circulatory and medullary eosinophilia revealing renal cell carcinoma. Presse Med. 1998;27(24):1218.","journal-title":"Presse Med"},{"issue":"5","key":"1685_CR23","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1111\/j.1523-1755.2005.00278.x","volume":"67","author":"H Liapis","year":"2005","unstructured":"Liapis H, Ho AK, Brown D, Mindel G, Gleich G. Thrombotic microangiopathy associated with the hypereosinophilic syndrome. Kidney Int. 2005;67(5):1806\u201311.","journal-title":"Kidney Int"},{"issue":"4","key":"1685_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1097\/01.TP.0000147318.48620.44","volume":"79","author":"S Meleg-Smith","year":"2005","unstructured":"Meleg-Smith S, Gauthier PM. Abundance of interstitial eosinophils in renal allografts is associated with vascular rejection. Transplant. 2005;79(4):444\u201350.","journal-title":"Transplant."},{"issue":"1","key":"1685_CR25","first-page":"69","volume":"26","author":"PD Thomson","year":"1994","unstructured":"Thomson PD, Meyers KE. Eosinophilia as an early predictor of acute cellular rejection in pediatric renal transplants. Transplant Proc. 1994;26(1):69\u201371.","journal-title":"Transplant Proc"},{"issue":"6","key":"1685_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00007890-198606000-00008","volume":"41","author":"MR Weir","year":"1986","unstructured":"Weir MR, Hall-Craggs M, Shen SY, Posner JN, Alongi SV, Dagher FJ, et al. The prognostic value of the eosinophil in acute renal allograft rejection. Transplant. 1986;41(6):709\u201312.","journal-title":"Transplant."},{"issue":"12","key":"1685_CR27","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1177\/039139880502801205","volume":"28","author":"W Gwinner","year":"2005","unstructured":"Gwinner W, Menne J, Lonnemann G, Bahlmann F, Koch KM, Haller H. Life-threatening complications of extracorporeal treatment in patients with severe eosinophilia. Int J Artif Organs. 2005;28(12):1224\u20137.","journal-title":"Int J Artif Organs"},{"issue":"4","key":"1685_CR28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/089686089701700419","volume":"17","author":"SS Thakur","year":"1997","unstructured":"Thakur SS, Unikowsky B, Prichard S. Eosinophilic peritonitis in CAPD: treatment with prednisone and diphenhydramine. Perit Dial Int. 1997;17(4):402\u20133.","journal-title":"Perit Dial Int"},{"issue":"2","key":"1685_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3904\/kjim.2004.19.2.121","volume":"19","author":"SY Oh","year":"2004","unstructured":"Oh SY, Kim H, Kang JM, Lim SH, Park HD, Jung SS, et al. Eosinophilic peritonitis in a patient with continuous ambulatory peritoneal dialysis (CAPD). Korean J Intern Med. 2004;19(2):121\u20133.","journal-title":"Korean J Intern Med"},{"issue":"3","key":"1685_CR30","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0272-6386(86)80023-3","volume":"8","author":"R Backenroth","year":"1986","unstructured":"Backenroth R, Spinowitz BS, Galler M, Golden RA, Rascoff JH, Charytan C. Comparison of eosinophilia in patients undergoing peritoneal dialysis and hemodialysis. Am J Kidney Dis. 1986;8(3):186\u201391.","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1685_CR31","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2215\/CJN.01330213","volume":"8","author":"AK Muriithi","year":"2013","unstructured":"Muriithi AK, Nasr SH, Leung N. Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol. 2013;8(11):1857\u201362.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1685_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/eji.200324429","volume":"34","author":"M Mariani","year":"2004","unstructured":"Mariani M, Lang R, Binda E, Panina-Bordignon P, D'Ambrosio D. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells. Eur J Immunol. 2004;34(1):231\u201340.","journal-title":"Eur J Immunol"},{"key":"1685_CR33","doi-asserted-by":"crossref","unstructured":"Moledina DG, Wilson FP, Pober JS, Perazella MA, Singh N, Luciano RL, et al. Urine TNF-alpha and IL-9 for clinical diagnosis of acute interstitial nephritis. JCI Insight. 2019;4(10).","DOI":"10.1172\/jci.insight.127456"},{"key":"1685_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2015.09.022","volume":"27","author":"L Vasaitis","year":"2016","unstructured":"Vasaitis L. IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med. 2016;27:1\u20139.","journal-title":"Eur J Intern Med"},{"issue":"9","key":"1685_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, Yi EE, Sato Y, Yoshino T, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25(9):1181\u201392.","journal-title":"Mod Pathol"},{"issue":"7","key":"1685_CR36","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/ndt\/14.7.1692","volume":"14","author":"FI Macdonald","year":"1999","unstructured":"Macdonald FI, Ashraf S, Picton M, Dyer PA, Parrott NR, Short CD, et al. Banff criteria as predictors of outcome following acute renal allograft rejection. Nephrol Dial Transplant. 1999;14(7):1692\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"1685_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2017.02.003","volume":"259","author":"Y Li","year":"2017","unstructured":"Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, et al. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis. 2017;259:75\u201382.","journal-title":"Atherosclerosis."},{"issue":"5","key":"1685_CR38","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1001\/jama.291.5.585","volume":"291","author":"TP Erlinger","year":"2004","unstructured":"Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA. 2004;291(5):585\u201390.","journal-title":"JAMA."},{"key":"1685_CR39","volume-title":"Epidemiology, beyond the basics","author":"MN Szklo","year":"2006","unstructured":"Szklo MN, Javier E. Epidemiology, beyond the basics; 2006."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-1685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-020-1685-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-1685-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T19:40:31Z","timestamp":1610394031000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-1685-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,13]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-1685-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.13162\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13162\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.13162\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,13]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research was conducted ethically in accordance with the World Medical Association of Helsinki. The study protocol was approved by the institutional review boards at Johns Hopkins University and Medical University of South Carolina. No patient consent was needed as it was waived by the institutional review boards given the observational nature of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}